Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.75, $0.08 better than the analyst estimate of $0.67. Revenue for the quarter came in at $4.66 billion versus the consensus estimate of $4.57 billion.

GUIDANCE:

Boston Scientific sees FY2025 EPS of $2.87-$2.94, versus the consensus of $2.86.

For earnings history and earnings-related data on Boston Scientific (BSX) click here.